<DOC>
	<DOC>NCT00079833</DOC>
	<brief_summary>This research study will determine if esomeprazole, when administered twice daily at 40, 80, or 120 mg doses, can control excessive stomach acid secretion.</brief_summary>
	<brief_title>Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Males or females at least 18 years of age. Diagnosis of ZollingerEllison Syndrome or idiopathic hypersecretion Pregnant or lactating females History of drug addiction or alcohol abuse within 12 months prior to Screening. History of intolerance to any proton pump inhibitors or any ingredient in their formulation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>gastric acid hypersecretory conditions</keyword>
	<keyword>Idiopathic Hypersecretion</keyword>
	<keyword>Excessive Gastric Acid secretion</keyword>
</DOC>